Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» United Therapeutics' Growth Driven By Approval Of Two New Treatments
United Therapeutics' Growth Driven By Approval Of Two New Treatments
United Therapeutics' Growth Driven By Approval Of Two New Treatments
Submitted by
admin
on August 18, 2009 - 6:24am
Source:
Yahoo/Investors Business Daily
News Tags:
United Therapeutics
Pfizer
Eli Lilly
Gilead Sciences
Tyvaso
Adcirca
Headline:
United Therapeutics' Growth Driven By Approval Of Two New Treatments
Do Not Allow Advertisers to Use My Personal information
